Calcium chloride cross-linked PAMAM grafted chitosan–alginate core–shell nanoparticles are demonstrated as potential low-toxicity carriers for oral insulin delivery.
No takes yet. Share an insight, caveat, or question.
Mukhopadhyay et al. (2015) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: